Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 861Lung Neoplasms 586Small Cell Lung Carcinoma 169Colorectal Neoplasms 134Breast Neoplasms 108Melanoma 101Neoplasms 91Ovarian Neoplasms 90Neoplasm Metastasis 84Pancreatic Neoplasms 75Squamous Cell Carcinoma of Head and Neck 69Stomach Neoplasms 60Carcinoma, Renal Cell 56Head and Neck Neoplasms 55Esophageal Neoplasms 49Triple Negative Breast Neoplasms 48Endometrial Neoplasms 47Prostatic Neoplasms 46Uterine Cervical Neoplasms 41Urinary Bladder Neoplasms 40Colonic Neoplasms 40Mesothelioma 38Carcinoma, Hepatocellular 36Mesothelioma, Malignant 34Brain Neoplasms 31Adenocarcinoma of Lung 29Sarcoma 28Carcinoma, Transitional Cell 28Lung Diseases 24Gastrointestinal Neoplasms 24

Interventions

Mass Screening 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lung Cancer Screening × Thoracic × 90 days × Clear all
NCT07517692 2026-05-14

FIX-SDM LCS

University of Massachusetts, Worcester

Phase NA Enrolling by invitation
120 enrolled
Thoracic

Lung Cancer Screening

NCT07408531 2026-04-13

LUNG-07: Advancing Precision-Based Lung Cancer Screening: Implementation, AI-Guided Risk Stratification, and Biomarker Integration (CREST AI)

University of Illinois at Chicago

Phase NA Recruiting
2,500 enrolled
Thoracic

Lung Cancer Screening

Data powered by HemOnc (CC BY 4.0) Colophon âš¡